Oncotype DX Recurrence Score and treatment choices according to ethnicity

被引：0
|
作者：
Cruz, Allan Louie Espino
Desale, Sameer
Swain, Sandra M.
Nunes, Raquel
机构：
[1] Medstar Washington Hosp Ctr, Washington, DC USA
[2] MedStar Hlth Res Inst, Washington, DC USA
[3] NSABP NRG Oncol, Washington, DC USA
[4] MedStar Washington Hosp Ctr, Washington Canc Inst, Washington, DC USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.e12010
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e12010
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Correlation of Oncotype Dx Recurrence Score and Luminal Subtypes of Breast Cancer
    Henderson, S.
    Xie, X-J
    Peng, Y.
    Euhus, D.
    Leitch, M.
    Rao, R.
    Haley, B.
    Sarode, V.
    CANCER RESEARCH, 2010, 70
  • [42] Survival results according to Oncotype Dx recurrence score in patients with hormone receptor positive HER-2 negative early-stage breast cancer: first multicenter Oncotype Dx recurrence score survival data of Turkey
    Unal, Caglar
    Ozmen, Tolga
    Ordu, Cetin
    Pilanci, Kezban Nur
    Ilgun, Ahmet Serkan
    Gokmen, Erhan
    Almuradova, Elvina
    Ozdogan, Mustafa
    Guler, Niluefer
    Uras, Cihan
    Kara, Halil
    Demircan, Orhan
    Isik, Selver
    Alco, Gul
    Saip, Pinar
    Aydin, Esra
    Duymaz, Tomris
    Celebi, Filiz
    Yararbas, Kanay
    Soybir, Gursel
    Ozmen, Vahit
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [43] Relationship of histologic grade and histologic subtype with oncotype Dx recurrence score; retrospective review of 863 breast cancer oncotype Dx results
    Kamaljeet Singh
    Xin He
    Elizabeth T. Kalife
    Shahrzad Ehdaivand
    Yihong Wang
    C. James Sung
    Breast Cancer Research and Treatment, 2018, 168 : 29 - 34
  • [44] The average modified Magee score can be helpful in predicting an Oncotype DX recurrence score ≤ 25
    Turner, B. M.
    Sanders, M. A.
    Breaux, A.
    Soukiazian, A.
    Soukiazian, N.
    Hicks, D. G.
    CANCER RESEARCH, 2019, 79 (04)
  • [45] Correlation of oncotype DX recurrence score with histologic grading and estrogen receptor positivity
    Bhargava, Rohit
    Dabbs, David
    Brufsky, Adam
    Beriwal, Sushil
    MODERN PATHOLOGY, 2006, 19 : 8 - 9
  • [46] Comparison of Oncotype-DX recurrence score and standard immunohistochemical prognostic markers
    Grimes, M. C.
    Coad, J.
    Oliverio, B. J.
    Bloom, K. J.
    MODERN PATHOLOGY, 2007, 20 : 33A - 33A
  • [47] Reproducibility of Oncotype Dx Recurrence Score Using Magee Equations in Breast Cancers
    Favazza, Laura
    Schultz, Daniel
    Chitale, Dhananjay
    MODERN PATHOLOGY, 2015, 28 : 44A - 44A
  • [48] Prediction of Oncotype DX Recurrence Score: Use of a Pathology-Generated Equation
    Hou, Yanjun
    Tozbikian, Gary
    Zynger, Debra L.
    Li, Zaibo
    LABORATORY INVESTIGATION, 2016, 96 : 45A - 45A
  • [49] Why does Oncotype DX recurrence score reduce adjuvant chemotherapy use?
    Schneider, Jeffrey G.
    Khalil, Danny N.
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 134 (03) : 1125 - 1132
  • [50] The prognostic role of Ki-67 in relation to Oncotype DX Recurrence Score
    Markopoulos, C.
    Koumarianou, A.
    Venizelos, V.
    Iosifidou, R.
    Papazisis, K.
    Tsoulos, N.
    Kapetsis, G.
    Giannoulakis, S.
    Giassas, S.
    Foivos, I.
    Gaki, V.
    Pazaiti, A.
    Anastasakou, K.
    Timotheadou, E.
    Koutsoukos, K.
    Kontoulis, T.
    Kostouros, E.
    Gkioulbasanis, I.
    Nasikas, D.
    Matheos, D.
    BREAST, 2025, 80
12345